INmune Bio Inc expected to post a loss of 44 cents a share - Earnings Preview

Inmune Bio

27/02/2024 21:24

* INmune Bio Inc  INMB.OQ   INMB.O  is expected to show a
fall in
quarterly revenue when it reports  results on February 29
(estimated) for the period ending December 31 2023
    * The Boca Raton Florida-based  company is expected to
report a
55.7% decrease in revenue to $43 thousand from $97 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for INmune Bio Inc is for a
loss
of 44 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$21.00​, above​ its last closing price of $13.11. ​​​

This summary was machine generated February 27 at 21:24 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)